EARNEST Partners’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,790,996
| Closed | -$48.1M | – | 287 |
|
|
2024
Q1 | $48.1M | Sell |
4,790,996
-27,094
| -0.6% | -$252K | 0.22% | 154 |
|
|
2023
Q4 | $44.8M | Sell |
4,818,090
-283,393
| -6% | -$2.93M | 0.22% | 149 |
|
|
2023
Q3 | $64.8M | Sell |
5,101,483
-215,045
| -4% | -$2.95M | 0.37% | 109 |
|
|
2023
Q2 | $75.5M | Sell |
5,316,528
-1,240,718
| -19% | -$17.4M | 0.42% | 102 |
|
|
2023
Q1 | $97.8M | Buy |
6,557,246
+10,666
| +0.2% | +$162K | 0.57% | 71 |
|
|
2022
Q4 | $97.3M | Sell |
6,546,580
-214,149
| -3% | -$3.49M | 0.6% | 70 |
|
|
2022
Q3 | $112M | Sell |
6,760,729
-65,173
| -1% | -$1.31M | 0.75% | 45 |
|
|
2022
Q2 | $143M | Buy |
6,825,902
+367,473
| +6% | +$7.5M | 0.96% | 26 |
|
|
2022
Q1 | $152M | Sell |
6,458,429
-165,971
| -3% | -$4.06M | 0.9% | 33 |
|
|
2021
Q4 | $180M | Sell |
6,624,400
-382,174
| -5% | -$10.2M | 1.04% | 27 |
|
|
2021
Q3 | $199M | Sell |
7,006,574
-88,115
| -1% | -$2.69M | 1.22% | 20 |
|
|
2021
Q2 | $214M | Buy |
7,094,689
+8,386
| +0.1% | +$247K | 1.26% | 15 |
|
|
2021
Q1 | $180M | Buy |
7,086,303
+1,149,651
| +19% | +$29.4M | 1.08% | 26 |
|
|
2020
Q4 | $146M | Buy |
5,936,652
+5,936,615
| +16,044,905% | +$111M | 1.01% | 28 |
|
|
2020
Q3 | $1K | Hold |
37
| – | – | ﹤0.01% | 1077 |
|
|
2020
Q2 | $1K | Hold |
37
| – | – | ﹤0.01% | 1061 |
|
|
2020
Q1 | $0 | Hold |
37
| – | – | ﹤0.01% | 1145 |
|
|
2019
Q4 | $1K | Hold |
37
| – | – | ﹤0.01% | 1105 |
|
|
2019
Q3 | $1K | Hold |
37
| – | – | ﹤0.01% | 1093 |
|
|
2019
Q2 | $1K | Sell |
37
-111,511
| -100% | -$3M | ﹤0.01% | 1110 |
|
|
2019
Q1 | $3.03M | Sell |
111,548
-1,785,677
| -94% | -$59.9M | 0.03% | 200 |
|
|
2018
Q4 | $62.6M | Sell |
1,897,225
-44,607
| -2% | -$1.79M | 0.68% | 63 |
|
|
2018
Q3 | $90.6M | Sell |
1,941,832
-536
| -0% | -$24.6K | 0.81% | 41 |
|
|
2018
Q2 | $84.1M | Sell |
1,942,368
-153,745
| -7% | -$7.37M | 0.79% | 47 |
|
|
2018
Q1 | $117M | Sell |
2,096,113
-116,578
| -5% | -$6.39M | 1.1% | 20 |
|
|
2017
Q4 | $118M | Buy |
2,212,691
+718,317
| +48% | +$33.9M | 1.13% | 20 |
|
|
2017
Q3 | $64.4M | Buy |
1,494,374
+11,037
| +0.7% | +$525K | 0.64% | 63 |
|
|
2017
Q2 | $89.5M | Buy |
1,483,337
+5,595
| +0.4% | +$332K | 0.94% | 36 |
|
|
2017
Q1 | $103M | Sell |
1,477,742
-18,027
| -1% | -$1.25M | 1.09% | 22 |
|
|
2016
Q4 | $99.7M | Sell |
1,495,769
-140,243
| -9% | -$9.12M | 1.09% | 22 |
|
|
2016
Q3 | $108M | Sell |
1,636,012
-84,412
| -5% | -$5.77M | 1.14% | 19 |
|
|
2016
Q2 | $125M | Sell |
1,720,424
-29,134
| -2% | -$2M | 1.35% | 14 |
|
|
2016
Q1 | $113M | Sell |
1,749,558
-31,163
| -2% | -$2.07M | 1.18% | 18 |
|
|
2015
Q4 | $128M | Sell |
1,780,721
-208,798
| -10% | -$15.4M | 1.3% | 15 |
|
|
2015
Q3 | $153M | Sell |
1,989,519
-97,695
| -5% | -$7.88M | 1.5% | 12 |
|
|
2015
Q2 | $155M | Sell |
2,087,214
-31,947
| -2% | -$2.3M | 1.35% | 14 |
|
|
2015
Q1 | $154M | Sell |
2,119,161
-194,993
| -8% | -$13.6M | 1.32% | 12 |
|
|
2014
Q4 | $153M | Sell |
2,314,154
-31,064
| -1% | -$1.9M | 1.26% | 12 |
|
|
2014
Q3 | $129M | Sell |
2,345,218
-12,033
| -0.5% | -$683K | 1.07% | 22 |
|
|
2014
Q2 | $137M | Sell |
2,357,251
-50,385
| -2% | -$2.96M | 1.09% | 21 |
|
|
2014
Q1 | $149M | Sell |
2,407,636
-87,214
| -3% | -$5.07M | 1.2% | 17 |
|
|
2013
Q4 | $133M | Buy |
+2,494,850
| New | +$134M | 1.07% | 24 |
|
Other funds holding MD
RCMNY
EARNEST Partners's MD Position: Q2 2024 in Review
EARNEST Partners sold out of Pediatrix Medical (MD) in Q2 2024, closing a stake of 4,790,996 shares — an estimated $48.1M sold.
EARNEST Partners first reported a position in MD in Q4 2013 and held it in 42 quarters. The position peaked at $214M in Q2 2021. 227 funds tracked by Wall St. Rank hold MD as of Q2 2024.
- EARNEST Partners reported no remaining Pediatrix Medical position as of Q2 2024 after selling out during the quarter.
- EARNEST Partners sold 4,790,996 Pediatrix Medical shares in Q2 2024, an estimated $48.1M.
- EARNEST Partners first reported a position in Pediatrix Medical in Q4 2013 and held it in 42 quarters.
- EARNEST Partners's Pediatrix Medical position peaked at $214M in Q2 2021.
- 227 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2024.
Based on EARNEST Partners's 13F filing for Q2 2024, filed 14 Aug 2024.